STOCK TITAN

[Form 4] Saga Communications, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Cardlytics, Inc. (CDLX) – Form 4 insider transaction: Chief Legal & Privacy Officer Nicholas Hollmeyer reported the vesting of three restricted-stock-unit (RSU) tranches on 01-Jul-2025, converting a total of 12,788 shares of CDLX common stock. On 02-Jul-2025 he sold 5,271 shares at a weighted-average price of $1.7826 per share. According to the filing, the sale was executed solely to satisfy tax-withholding obligations generated by the RSU delivery.

Following the transactions, Hollmeyer’s direct ownership stands at 109,636 common shares. He also retains 39,945 unvested RSUs across three awards that continue to vest quarterly through 01-Apr-2026. No other insider relationships or indirect holdings were disclosed.

The activity represents a routine equity compensation event rather than a discretionary sale. The net effect is a modest increase in the executive’s equity exposure (shares acquired minus shares sold equals +7,517). Given CDLX’s low absolute share price, the dollar value of the tax-sale (~$9.4 k) is immaterial to the company and is unlikely to influence the investment thesis.

Cardlytics, Inc. (CDLX) – Transazione interna Form 4: Il Chief Legal & Privacy Officer Nicholas Hollmeyer ha segnalato il vesting di tre tranche di unità azionarie vincolate (RSU) il 01-lug-2025, convertendo un totale di 12.788 azioni ordinarie CDLX. Il 02-lug-2025 ha venduto 5.271 azioni a un prezzo medio ponderato di $1,7826 per azione. Secondo la dichiarazione, la vendita è stata effettuata esclusivamente per soddisfare gli obblighi fiscali derivanti dalla consegna delle RSU.

Dopo queste operazioni, la proprietà diretta di Hollmeyer ammonta a 109.636 azioni ordinarie. Mantiene inoltre 39.945 RSU non maturate distribuite su tre premi che continueranno a maturare trimestralmente fino al 01-apr-2026. Non sono state dichiarate altre relazioni interne o partecipazioni indirette.

L’attività rappresenta un evento di compensazione azionaria di routine piuttosto che una vendita discrezionale. L’effetto netto è un modesto aumento dell’esposizione azionaria dell’esecutivo (azioni acquisite meno azioni vendute pari a +7.517). Considerando il basso prezzo assoluto delle azioni CDLX, il valore in dollari della vendita per tasse (~9,4 mila $) è irrilevante per la società e probabilmente non influenzerà la tesi d’investimento.

Cardlytics, Inc. (CDLX) – Transacción interna Formulario 4: El Director Legal y de Privacidad Nicholas Hollmeyer informó la consolidación de tres tramos de unidades de acciones restringidas (RSU) el 01-jul-2025, convirtiendo un total de 12,788 acciones ordinarias de CDLX. El 02-jul-2025 vendió 5,271 acciones a un precio promedio ponderado de $1.7826 por acción. Según el informe, la venta se realizó únicamente para cumplir con las obligaciones fiscales generadas por la entrega de las RSU.

Tras las transacciones, la propiedad directa de Hollmeyer es de 109,636 acciones ordinarias. También conserva 39,945 RSU no consolidadas repartidas en tres premios que continúan consolidándose trimestralmente hasta el 01-abr-2026. No se divulgaron otras relaciones internas ni participaciones indirectas.

La actividad representa un evento rutinario de compensación de acciones más que una venta discrecional. El efecto neto es un aumento modesto en la exposición accionarial del ejecutivo (acciones adquiridas menos acciones vendidas igual a +7,517). Dado el bajo precio absoluto de las acciones de CDLX, el valor en dólares de la venta por impuestos (~$9.4 mil) es insignificante para la empresa y probablemente no influirá en la tesis de inversión.

Cardlytics, Inc. (CDLX) – Form 4 내부자 거래: 최고 법률 및 개인정보 책임자 Nicholas Hollmeyer가 2025년 7월 1일에 세 개의 제한 주식 단위(RSU) 트랜치를 베스팅하여 총 12,788주의 CDLX 보통주로 전환했다고 보고했습니다. 2025년 7월 2일에는 주당 가중평균 가격 $1.78265,271주를 매도했습니다. 제출서류에 따르면, 이 매도는 RSU 지급으로 인한 세금 원천징수 의무를 충족하기 위해서만 실행되었습니다.

거래 후 Hollmeyer의 직접 소유 주식은 109,636주입니다. 또한 2026년 4월 1일까지 분기별로 베스팅되는 세 개의 상에서 39,945개의 미베스팅 RSU를 보유하고 있습니다. 기타 내부자 관계나 간접 소유는 공개되지 않았습니다.

이번 활동은 임의 매도가 아닌 일상적인 주식 보상 이벤트를 나타냅니다. 순효과는 경영진의 주식 노출이 소폭 증가한 것입니다(취득 주식 수에서 매도 주식 수를 뺀 값은 +7,517). CDLX의 낮은 절대 주가를 고려할 때, 세금 매도 금액(~9,400달러)은 회사에 미미한 영향만 주며 투자 논리에 큰 영향을 미치지 않을 것입니다.

Cardlytics, Inc. (CDLX) – Transaction d’initié Formulaire 4 : Le Chief Legal & Privacy Officer, Nicholas Hollmeyer, a déclaré la levée de trois tranches d’unités d’actions restreintes (RSU) le 1er juillet 2025, convertissant au total 12 788 actions ordinaires CDLX. Le 2 juillet 2025, il a vendu 5 271 actions à un prix moyen pondéré de 1,7826 $ par action. Selon le dépôt, cette vente a été effectuée uniquement pour satisfaire les obligations fiscales générées par la livraison des RSU.

Après ces transactions, la détention directe de Hollmeyer s’élève à 109 636 actions ordinaires. Il conserve également 39 945 RSU non acquises réparties sur trois attributions qui continueront de s’acquérir trimestriellement jusqu’au 1er avril 2026. Aucune autre relation d’initié ou détention indirecte n’a été divulguée.

Cette opération représente un événement courant de rémunération en actions plutôt qu’une vente discrétionnaire. L’effet net est une augmentation modérée de l’exposition en actions du dirigeant (actions acquises moins actions vendues = +7 517). Étant donné le faible cours absolu de CDLX, la valeur en dollars de la vente pour impôts (~9,4 k$) est négligeable pour la société et ne devrait pas influencer la thèse d’investissement.

Cardlytics, Inc. (CDLX) – Insider-Transaktion Form 4: Chief Legal & Privacy Officer Nicholas Hollmeyer meldete die Vesting von drei Tranchen von Restricted Stock Units (RSUs) am 01. Juli 2025, wodurch insgesamt 12.788 Aktien der CDLX-Stammaktien umgewandelt wurden. Am 02. Juli 2025 verkaufte er 5.271 Aktien zu einem gewichteten Durchschnittspreis von $1,7826 pro Aktie. Laut der Meldung wurde der Verkauf ausschließlich zur Begleichung von Steuerabzugsverpflichtungen im Zusammenhang mit der RSU-Ausgabe durchgeführt.

Nach den Transaktionen hält Hollmeyer direkt 109.636 Stammaktien. Zudem besitzt er 39.945 nicht unverfallbare RSUs aus drei Auszeichnungen, die weiterhin vierteljährlich bis zum 01. April 2026 vesten. Weitere Insider-Beziehungen oder indirekte Beteiligungen wurden nicht offengelegt.

Die Aktivität stellt ein routinemäßiges Aktieneinkommensereignis dar und keine freiwillige Veräußerung. Die Nettoauswirkung ist ein moderater Anstieg der Aktienexponierung des Executives (erworbene Aktien minus verkaufte Aktien = +7.517). Angesichts des niedrigen absoluten Aktienkurses von CDLX ist der Dollarwert des Steuerverkaufs (~9,4 Tsd. $) für das Unternehmen unerheblich und wird die Investmentthese wahrscheinlich nicht beeinflussen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine RSU vesting; small tax-related sale, immaterial to valuation.

The filing documents standard quarterly RSU vesting for a senior officer. Although 5,271 shares were sold, the purpose was tax withholding, not discretionary profit-taking, limiting any negative signal. Net share ownership increased, and the remaining 39.9 k RSUs sustain management’s long-term incentive alignment. With an estimated sale value below $10 k and no change to executive roles or corporate strategy, I view the disclosure as neutral from a market-impact perspective.

Cardlytics, Inc. (CDLX) – Transazione interna Form 4: Il Chief Legal & Privacy Officer Nicholas Hollmeyer ha segnalato il vesting di tre tranche di unità azionarie vincolate (RSU) il 01-lug-2025, convertendo un totale di 12.788 azioni ordinarie CDLX. Il 02-lug-2025 ha venduto 5.271 azioni a un prezzo medio ponderato di $1,7826 per azione. Secondo la dichiarazione, la vendita è stata effettuata esclusivamente per soddisfare gli obblighi fiscali derivanti dalla consegna delle RSU.

Dopo queste operazioni, la proprietà diretta di Hollmeyer ammonta a 109.636 azioni ordinarie. Mantiene inoltre 39.945 RSU non maturate distribuite su tre premi che continueranno a maturare trimestralmente fino al 01-apr-2026. Non sono state dichiarate altre relazioni interne o partecipazioni indirette.

L’attività rappresenta un evento di compensazione azionaria di routine piuttosto che una vendita discrezionale. L’effetto netto è un modesto aumento dell’esposizione azionaria dell’esecutivo (azioni acquisite meno azioni vendute pari a +7.517). Considerando il basso prezzo assoluto delle azioni CDLX, il valore in dollari della vendita per tasse (~9,4 mila $) è irrilevante per la società e probabilmente non influenzerà la tesi d’investimento.

Cardlytics, Inc. (CDLX) – Transacción interna Formulario 4: El Director Legal y de Privacidad Nicholas Hollmeyer informó la consolidación de tres tramos de unidades de acciones restringidas (RSU) el 01-jul-2025, convirtiendo un total de 12,788 acciones ordinarias de CDLX. El 02-jul-2025 vendió 5,271 acciones a un precio promedio ponderado de $1.7826 por acción. Según el informe, la venta se realizó únicamente para cumplir con las obligaciones fiscales generadas por la entrega de las RSU.

Tras las transacciones, la propiedad directa de Hollmeyer es de 109,636 acciones ordinarias. También conserva 39,945 RSU no consolidadas repartidas en tres premios que continúan consolidándose trimestralmente hasta el 01-abr-2026. No se divulgaron otras relaciones internas ni participaciones indirectas.

La actividad representa un evento rutinario de compensación de acciones más que una venta discrecional. El efecto neto es un aumento modesto en la exposición accionarial del ejecutivo (acciones adquiridas menos acciones vendidas igual a +7,517). Dado el bajo precio absoluto de las acciones de CDLX, el valor en dólares de la venta por impuestos (~$9.4 mil) es insignificante para la empresa y probablemente no influirá en la tesis de inversión.

Cardlytics, Inc. (CDLX) – Form 4 내부자 거래: 최고 법률 및 개인정보 책임자 Nicholas Hollmeyer가 2025년 7월 1일에 세 개의 제한 주식 단위(RSU) 트랜치를 베스팅하여 총 12,788주의 CDLX 보통주로 전환했다고 보고했습니다. 2025년 7월 2일에는 주당 가중평균 가격 $1.78265,271주를 매도했습니다. 제출서류에 따르면, 이 매도는 RSU 지급으로 인한 세금 원천징수 의무를 충족하기 위해서만 실행되었습니다.

거래 후 Hollmeyer의 직접 소유 주식은 109,636주입니다. 또한 2026년 4월 1일까지 분기별로 베스팅되는 세 개의 상에서 39,945개의 미베스팅 RSU를 보유하고 있습니다. 기타 내부자 관계나 간접 소유는 공개되지 않았습니다.

이번 활동은 임의 매도가 아닌 일상적인 주식 보상 이벤트를 나타냅니다. 순효과는 경영진의 주식 노출이 소폭 증가한 것입니다(취득 주식 수에서 매도 주식 수를 뺀 값은 +7,517). CDLX의 낮은 절대 주가를 고려할 때, 세금 매도 금액(~9,400달러)은 회사에 미미한 영향만 주며 투자 논리에 큰 영향을 미치지 않을 것입니다.

Cardlytics, Inc. (CDLX) – Transaction d’initié Formulaire 4 : Le Chief Legal & Privacy Officer, Nicholas Hollmeyer, a déclaré la levée de trois tranches d’unités d’actions restreintes (RSU) le 1er juillet 2025, convertissant au total 12 788 actions ordinaires CDLX. Le 2 juillet 2025, il a vendu 5 271 actions à un prix moyen pondéré de 1,7826 $ par action. Selon le dépôt, cette vente a été effectuée uniquement pour satisfaire les obligations fiscales générées par la livraison des RSU.

Après ces transactions, la détention directe de Hollmeyer s’élève à 109 636 actions ordinaires. Il conserve également 39 945 RSU non acquises réparties sur trois attributions qui continueront de s’acquérir trimestriellement jusqu’au 1er avril 2026. Aucune autre relation d’initié ou détention indirecte n’a été divulguée.

Cette opération représente un événement courant de rémunération en actions plutôt qu’une vente discrétionnaire. L’effet net est une augmentation modérée de l’exposition en actions du dirigeant (actions acquises moins actions vendues = +7 517). Étant donné le faible cours absolu de CDLX, la valeur en dollars de la vente pour impôts (~9,4 k$) est négligeable pour la société et ne devrait pas influencer la thèse d’investissement.

Cardlytics, Inc. (CDLX) – Insider-Transaktion Form 4: Chief Legal & Privacy Officer Nicholas Hollmeyer meldete die Vesting von drei Tranchen von Restricted Stock Units (RSUs) am 01. Juli 2025, wodurch insgesamt 12.788 Aktien der CDLX-Stammaktien umgewandelt wurden. Am 02. Juli 2025 verkaufte er 5.271 Aktien zu einem gewichteten Durchschnittspreis von $1,7826 pro Aktie. Laut der Meldung wurde der Verkauf ausschließlich zur Begleichung von Steuerabzugsverpflichtungen im Zusammenhang mit der RSU-Ausgabe durchgeführt.

Nach den Transaktionen hält Hollmeyer direkt 109.636 Stammaktien. Zudem besitzt er 39.945 nicht unverfallbare RSUs aus drei Auszeichnungen, die weiterhin vierteljährlich bis zum 01. April 2026 vesten. Weitere Insider-Beziehungen oder indirekte Beteiligungen wurden nicht offengelegt.

Die Aktivität stellt ein routinemäßiges Aktieneinkommensereignis dar und keine freiwillige Veräußerung. Die Nettoauswirkung ist ein moderater Anstieg der Aktienexponierung des Executives (erworbene Aktien minus verkaufte Aktien = +7.517). Angesichts des niedrigen absoluten Aktienkurses von CDLX ist der Dollarwert des Steuerverkaufs (~9,4 Tsd. $) für das Unternehmen unerheblich und wird die Investmentthese wahrscheinlich nicht beeinflussen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Edward K. Christian Trust

(Last) (First) (Middle)
500 WOODWARD AVENUE
SUITE 4000

(Street)
DETROIT MI 48226

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SAGA COMMUNICATIONS INC [ SGA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/01/2025 S 6,269 D $13.047(1) 914,008 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.38, inclusive. The Reporting Person undertakes to provide Saga Communications, Inc., any security holder of Saga Communications, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Judith Christian, Trustee 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many CDLX shares did Nicholas Hollmeyer acquire through RSU vesting?

12,788 shares vested and converted to common stock on 01-Jul-2025.

What was the sale price for the CDLX shares sold on 02-Jul-2025?

The weighted-average sale price was $1.7826 per share, within a $1.66–$1.8451 range.

How many CDLX shares does the insider own after the transactions?

Direct ownership is 109,636 common shares plus 39,945 unvested RSUs.

Why were shares sold by the insider?

All shares sold were solely to cover tax-withholding obligations arising from RSU vesting.

Do the transactions indicate a change in insider sentiment toward Cardlytics (CDLX)?

The filing appears routine; net ownership increased, so it does not signal a bearish outlook.
Saga Coms

NASDAQ:SGA

SGA Rankings

SGA Latest News

SGA Latest SEC Filings

SGA Stock Data

82.13M
4.65M
25.01%
64.33%
0.09%
Broadcasting
Radio Broadcasting Stations
Link
United States
GROSSE POINTE FARMS